The effect of clonidine on cell survival, glutamate, and aspartate release in normo- and hyperglycemic rats after near complete forebrain ischemia

W. Scott Jellish, John Murdoch, Gisela Kindel, Xin Zhang, Fletcher White

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The present study was undertaken to investigate the effects of the α2 adrenergic agonist, clonidine, on the near complete cerebral ischemia (NCFI) evoked release of glutamate and aspartate from normo- and hyperglycemic rodent brain tissue using microdialysis tissue techniques. Hemodynamic variables, blood lactate, and glucose levels were monitored throughout the 40 min NCFI occlusion period. After 48 h, rats were killed and the extent of neuronal injury was determined in the cortex, striatum, and hippocampus. Hemodynamic variables recorded during ischemia improved with clonidine treatment in both normo- and hyperglycemic groups. Glutamate and aspartate levels were greatly increased over control values during normo- and hyperglycemic NCFI treatment. Clonidine pretreatment suppressed the release of both glutamate and aspartate during NCFI in normo- and hyperglycemic rodents when compared with NCFI-treated normo- and hyperglycemic rats without the drug. Significant neuroprotection of cells in the cortex, striatum, and hippocampus was also observed in drug-treated animals 48 h postischemia. The combined effects of diminished glutamate release after NCFI and reduced neuronal injury in both normo- and hyperglycemic states suggests that clonidine treatment during NCFI is neuroprotective. The neuroprotective effect of clonidine during ischemia may be ascribed to both a sensitization of central sympathetic activity and a reduced release of glutamate thereby reducing NMDA receptor activation and neuronal damage.

Original languageEnglish (US)
Pages (from-to)526-534
Number of pages9
JournalExperimental Brain Research
Volume167
Issue number4
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Clonidine
Prosencephalon
Aspartic Acid
Glutamic Acid
Cell Survival
Ischemia
Rodentia
Hippocampus
Hemodynamics
Central Nervous System Sensitization
Adrenergic Agonists
Microdialysis
Wounds and Injuries
Neuroprotective Agents
N-Methyl-D-Aspartate Receptors
Brain Ischemia
Pharmaceutical Preparations
Blood Glucose
Lactic Acid
Brain

Keywords

  • α2 agonists
  • Glutamate
  • Hyperglycemia
  • Near complete forebrain ischemia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The effect of clonidine on cell survival, glutamate, and aspartate release in normo- and hyperglycemic rats after near complete forebrain ischemia. / Jellish, W. Scott; Murdoch, John; Kindel, Gisela; Zhang, Xin; White, Fletcher.

In: Experimental Brain Research, Vol. 167, No. 4, 12.2005, p. 526-534.

Research output: Contribution to journalArticle

@article{15bbf517c26647e5b41024fa831e6694,
title = "The effect of clonidine on cell survival, glutamate, and aspartate release in normo- and hyperglycemic rats after near complete forebrain ischemia",
abstract = "The present study was undertaken to investigate the effects of the α2 adrenergic agonist, clonidine, on the near complete cerebral ischemia (NCFI) evoked release of glutamate and aspartate from normo- and hyperglycemic rodent brain tissue using microdialysis tissue techniques. Hemodynamic variables, blood lactate, and glucose levels were monitored throughout the 40 min NCFI occlusion period. After 48 h, rats were killed and the extent of neuronal injury was determined in the cortex, striatum, and hippocampus. Hemodynamic variables recorded during ischemia improved with clonidine treatment in both normo- and hyperglycemic groups. Glutamate and aspartate levels were greatly increased over control values during normo- and hyperglycemic NCFI treatment. Clonidine pretreatment suppressed the release of both glutamate and aspartate during NCFI in normo- and hyperglycemic rodents when compared with NCFI-treated normo- and hyperglycemic rats without the drug. Significant neuroprotection of cells in the cortex, striatum, and hippocampus was also observed in drug-treated animals 48 h postischemia. The combined effects of diminished glutamate release after NCFI and reduced neuronal injury in both normo- and hyperglycemic states suggests that clonidine treatment during NCFI is neuroprotective. The neuroprotective effect of clonidine during ischemia may be ascribed to both a sensitization of central sympathetic activity and a reduced release of glutamate thereby reducing NMDA receptor activation and neuronal damage.",
keywords = "α2 agonists, Glutamate, Hyperglycemia, Near complete forebrain ischemia",
author = "Jellish, {W. Scott} and John Murdoch and Gisela Kindel and Xin Zhang and Fletcher White",
year = "2005",
month = "12",
doi = "10.1007/s00221-005-0064-4",
language = "English (US)",
volume = "167",
pages = "526--534",
journal = "Experimental Brain Research",
issn = "0014-4819",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The effect of clonidine on cell survival, glutamate, and aspartate release in normo- and hyperglycemic rats after near complete forebrain ischemia

AU - Jellish, W. Scott

AU - Murdoch, John

AU - Kindel, Gisela

AU - Zhang, Xin

AU - White, Fletcher

PY - 2005/12

Y1 - 2005/12

N2 - The present study was undertaken to investigate the effects of the α2 adrenergic agonist, clonidine, on the near complete cerebral ischemia (NCFI) evoked release of glutamate and aspartate from normo- and hyperglycemic rodent brain tissue using microdialysis tissue techniques. Hemodynamic variables, blood lactate, and glucose levels were monitored throughout the 40 min NCFI occlusion period. After 48 h, rats were killed and the extent of neuronal injury was determined in the cortex, striatum, and hippocampus. Hemodynamic variables recorded during ischemia improved with clonidine treatment in both normo- and hyperglycemic groups. Glutamate and aspartate levels were greatly increased over control values during normo- and hyperglycemic NCFI treatment. Clonidine pretreatment suppressed the release of both glutamate and aspartate during NCFI in normo- and hyperglycemic rodents when compared with NCFI-treated normo- and hyperglycemic rats without the drug. Significant neuroprotection of cells in the cortex, striatum, and hippocampus was also observed in drug-treated animals 48 h postischemia. The combined effects of diminished glutamate release after NCFI and reduced neuronal injury in both normo- and hyperglycemic states suggests that clonidine treatment during NCFI is neuroprotective. The neuroprotective effect of clonidine during ischemia may be ascribed to both a sensitization of central sympathetic activity and a reduced release of glutamate thereby reducing NMDA receptor activation and neuronal damage.

AB - The present study was undertaken to investigate the effects of the α2 adrenergic agonist, clonidine, on the near complete cerebral ischemia (NCFI) evoked release of glutamate and aspartate from normo- and hyperglycemic rodent brain tissue using microdialysis tissue techniques. Hemodynamic variables, blood lactate, and glucose levels were monitored throughout the 40 min NCFI occlusion period. After 48 h, rats were killed and the extent of neuronal injury was determined in the cortex, striatum, and hippocampus. Hemodynamic variables recorded during ischemia improved with clonidine treatment in both normo- and hyperglycemic groups. Glutamate and aspartate levels were greatly increased over control values during normo- and hyperglycemic NCFI treatment. Clonidine pretreatment suppressed the release of both glutamate and aspartate during NCFI in normo- and hyperglycemic rodents when compared with NCFI-treated normo- and hyperglycemic rats without the drug. Significant neuroprotection of cells in the cortex, striatum, and hippocampus was also observed in drug-treated animals 48 h postischemia. The combined effects of diminished glutamate release after NCFI and reduced neuronal injury in both normo- and hyperglycemic states suggests that clonidine treatment during NCFI is neuroprotective. The neuroprotective effect of clonidine during ischemia may be ascribed to both a sensitization of central sympathetic activity and a reduced release of glutamate thereby reducing NMDA receptor activation and neuronal damage.

KW - α2 agonists

KW - Glutamate

KW - Hyperglycemia

KW - Near complete forebrain ischemia

UR - http://www.scopus.com/inward/record.url?scp=28244477368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28244477368&partnerID=8YFLogxK

U2 - 10.1007/s00221-005-0064-4

DO - 10.1007/s00221-005-0064-4

M3 - Article

VL - 167

SP - 526

EP - 534

JO - Experimental Brain Research

JF - Experimental Brain Research

SN - 0014-4819

IS - 4

ER -